101. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
- Author
-
Bayard S, Langenier MC, and Dauvilliers Y
- Subjects
- Benzothiazoles adverse effects, Case-Control Studies, Dopamine Agonists adverse effects, Female, Gambling etiology, Humans, Impulsive Behavior etiology, Indoles adverse effects, Interview, Psychological, Male, Middle Aged, Neuropsychological Tests, Pramipexole, Prospective Studies, Restless Legs Syndrome psychology, Surveys and Questionnaires, Benzothiazoles therapeutic use, Decision Making drug effects, Dopamine Agonists therapeutic use, Indoles therapeutic use, Restless Legs Syndrome drug therapy, Reward
- Abstract
Study Objectives: To assess whether the frequency of impulse control disorders (ICDs), addictive behaviors, impulsivity, and impairment of decision-making task performance under ambiguous and risky conditions were present in patients with restless legs syndrome (RLS) and whether changes could be related to dopaminergic medications., Design: Case-control prospective study., Setting: Academic Sleep Disorders Center., Participants: Of the 149 participants, there were 39 who were drug free with primary RLS, 50 who were taking dopamine agonists (DA), and 60 control subjects. Participants were assessed with a clinical interview screening for ICDs, augmentation syndrome, impulsivity, depression, and addictive behaviors. All participants completed two decision-making tasks, one under an ambiguous condition (Iowa Gambling Task) and the other under a risky condition (Game of Dice Task). Drug-free patients with RLS underwent 1 night of polysomnography recording., Measurements and Results: Seventy percent of patients were treated with pramipexole (median dose, 0.36 mg), and 30% with ropinirole (median dose, 0.75 mg). Median duration of DA intake was 11 mo (range, 1-72 mo). No differences were found on impulsivity scores, ICDs, and substance addiction between drug-free patients or those taking DA, or control subjects. Patients with RLS reported more depressive symptoms than control subjects, but without differences between patients taking or not taking DA. Drug-free and treated patients demonstrated reduced performances on the Iowa Gambling Task but not on the Game of Dice Task compared to control subjects, with no differences between patients taking medications and those who were not. No association was found between decision-making task performances, or polysomnographic and clinical variables., Conclusion: Impulse control disorders, impulsivity, and substance addiction were infrequent in drug-free patients with restless legs syndrome or those treated with a low dose of dopamine agonists. However, patients with restless legs syndrome, either drug free or taking dopamine agonists, had preferences toward risky choices on the Iowa Gambling Task, which led to negative consequences in the long run, a condition potentially leading to further development of impulse control disorders.
- Published
- 2013
- Full Text
- View/download PDF